Cryotherapy & Oxaliplatin
Key facts
- Who runs it
- NYU Langone Health
- Where
- Mineola and New York, United StatesSee the 2 sites
- Trial code
- Status
- Suspended
- People taking part
- 40 people, planned
- Started
- 13 Mar 2025
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Cryotherapy Gloves
- Record updated
- 6 March 2026
- Why it stopped
- Study paused to enrollment
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Over the age of 18 years
- Willingness to participate in research
- Diagnosed with stage III colon cancer
- Chemotherapy naïve
- Planning to initiate Capecitabine + Oxaliplatin (CAPOX) chemotherapy regimen as part of standard of care
Who cannot take part
- Pre-existing diabetes
- Raynaud's disease
- Metabolic syndrome, including: Hypertension; Hypercholesterolemia; and Obesity (BSA > 2)
- Specific autoimmune diseases: Guillain-Barre; Lupus; Rheumatoid arthritis; and Sjogren's syndrome
- Pre-existing peripheral neuropathy
- Upper extremity amputees
Where in United States
- NYU Langone HealthMineola, United States
- NYU Langone HealthNew York, United States
About the trial
What the trial wants to find out
The primary objective of this study is to determine if cryotherapy is beneficial to patients with colon cancer who are receiving oxaliplatin in the prevention of developing chemotherapy induced peripheral neuropathy.
The 2 groups in the trial
- CryotherapyTreatment being tested
Patients receiving oxaliplatin who are randomized to the Interventional (Cryotherapy) Arm will wear a pair of gloves that has removable ice packs throughout their treatment, starting 15 minutes before and ending 15 minutes after completion of oxaliplatin. These ice packs will be replaced every 30 minutes. The total wearing time of the cryotherapy will be approximately 2 hours.
Treatment: Cryotherapy Gloves
- ControlNo study treatment, for comparison
Patients receiving oxaliplatin who are randomized to the Control Arm will not receive the gloves with removable ice packs throughout their treatment.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Phase II Randomized Interventional Pilot Study for Colon Cancer Patients Receiving Oxaliplatin: Benefits of Cryotherapy in Prevention of Peripheral Neuropathy
- Record updated
- 6 March 2026